Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Radiofrequency Ablation of Rammii Communicans Versus Annuloplasty or Both Together in Discogenic Back Pain Patients Double-Blinded Randomized Controlled Trial

NCT07360444 is registered in ClinicalTrials.gov with Esraa Fathy Radwan Abd Elzaher as lead sponsor.

NCT NCT07360444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07360444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Radiofrequency Ablation of Rammii Communicans Versus Annuloplasty or Both Together in Discogenic Back Pain Patients Double-Blinded Randomized Controlled Trial
Lead sponsor
Esraa Fathy Radwan Abd Elzaher
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 30, 2026
Completion date
January 31, 2029
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

discogenic back pain patients